337
Views
21
CrossRef citations to date
0
Altmetric
Reviews

QSAR studies in the discovery of novel type-II diabetic therapies

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

David Cabezas, Guido Mellado, Nicolás Espinoza, José Antonio Gárate, César Morales, Alejandro Castro-Alvarez, Maria J. Matos, Marco Mellado & Jaime Mella. (2023) In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies. Journal of Biomolecular Structure and Dynamics 41:22, pages 13250-13259.
Read now
Ifeoluwa Temitayo Oyeyemi, Kayode Ezekiel Adewole & Gideon Ampoma Gyebi. (2023) In silico prediction of the possible antidiabetic and anti-inflammatory targets of Nymphaea lotus-derived phytochemicals and mechanistic insights by molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics 41:21, pages 12225-12241.
Read now
Angélica Nakagawa Lima, Eric Allison Philot, Gustavo Henrique Goulart Trossini, Luis Paulo Barbour Scott, Vinícius Gonçalves Maltarollo & Kathia Maria Honorio. (2016) Use of machine learning approaches for novel drug discovery. Expert Opinion on Drug Discovery 11:3, pages 225-239.
Read now

Articles from other publishers (18)

Manoj Kumar Gupta, Gayatri Gouda, Sumreen Sultana, Shital Manohar Punekar, Ramakrishna Vadde & Tekupalli Ravikiran. 2023. 241 295 .
Shada J. Alabed, Malek Zihlif & Mutasem Taha. (2022) Discovery of new potent lysine specific histone demythelase-1 inhibitors (LSD-1) using structure based and ligand based molecular modelling and machine learning. RSC Advances 12:55, pages 35873-35895.
Crossref
Ana Maria Udrea, Gratiela Gradisteanu Pircalabioru, Anca Andreea Boboc, Catalina Mares, Andra Dinache, Maria Mernea & Speranta Avram. (2021) Advanced Bioinformatics Tools in the Pharmacokinetic Profiles of Natural and Synthetic Compounds with Anti-Diabetic Activity. Biomolecules 11:11, pages 1692.
Crossref
Zheng-Kun Kuang, Xi-Yao Cheng, Zi-Xin Yang, Yu-Xi Guo, Yong-Qi Huang & Zheng-Ding Su. (2021) In silico prediction of GLP-1R agonists using machine learning approach. Chemical Papers 75:7, pages 3587-3598.
Crossref
Oluwafemi Adeleke Ojo, Abayomi Emmanuel Adegboyega, Grace Inioluwa Johnson, Ngozi Lillian Umedum, Kingsley Onuh, Mary Nneka Adeduro, Valentine Osita Nwobodo, Ayodele O. Elekan, Taiwo Emmanuel Alemika & Titilayo Omolara Johnson. (2021) Deciphering the interactions of compounds from Allium sativum targeted towards identification of novel PTP 1B inhibitors in diabetes treatment: A computational approach. Informatics in Medicine Unlocked 26, pages 100719.
Crossref
Patnala Ganga Raju Achary. (2020) Applications of Quantitative Structure-Activity Relationships (QSAR) based Virtual Screening in Drug Design: A Review. Mini-Reviews in Medicinal Chemistry 20:14, pages 1375-1388.
Crossref
Holli-Joi Sullivan, Xiaoyan Wang, Shaina Nogle, Siyan Liao & Chun Wu. (2020) To Probe Full and Partial Activation of Human Peroxisome Proliferator-Activated Receptors by Pan-Agonist Chiglitazar Using Molecular Dynamics Simulations. PPAR Research 2020, pages 1-24.
Crossref
Anthony J. Hickey & Hugh D.C. SmythAnthony J. Hickey & Hugh D. C. Smyth. 2020. Pharmaco-complexity. Pharmaco-complexity 53 62 .
Elham Y. Al-Barghouthy, Areej Abuhammad & Mutasem O. Taha. (2019) QSAR-guided pharmacophore modeling and subsequent virtual screening identify novel TYK2 inhibitor. Medicinal Chemistry Research 28:9, pages 1368-1387.
Crossref
Lina A. Dahabiyeh, Yasser Bustanji & Mutasem O. Taha. (2019) The herbicide quinclorac as potent lipase inhibitor: Discovery via virtual screening and in vitro/in vivo validation. Chemical Biology & Drug Design 93:5, pages 787-797.
Crossref
Ma’mon M. Hatmal & Mutasem O. Taha. (2018) Combining Stochastic Deformation/Relaxation and Intermolecular Contacts Analysis for Extracting Pharmacophores from Ligand–Receptor Complexes. Journal of Chemical Information and Modeling 58:4, pages 879-893.
Crossref
Areej Abuhammad, Rua'a A. Al‐Aqtash, Brandon J. Anson, Andrew D. Mesecar & Mutasem O. Taha. (2017) Computational modeling of the bat HKU4 coronavirus 3CL pro inhibitors as a tool for the development of antivirals against the emerging M iddle E ast respiratory syndrome ( MERS ) coronavirus . Journal of Molecular Recognition 30:11.
Crossref
Ma'mon M Hatmal & Mutasem O Taha. (2017) Simulated annealing molecular dynamics and ligand–receptor contacts analysis for pharmacophore modeling. Future Medicinal Chemistry 9:11, pages 1141-1159.
Crossref
Mahmoud A. Al-Sha'er, Inas S. Almazari & Mutasem O. Taha. (2017) Discovery of novel potent nuclear factor kappa-B inhibitors (IKK-β) via extensive ligand-based modeling and virtual screening. Journal of Molecular Recognition 30:6, pages e2604.
Crossref
Y.J. Qi, H.N. Lu, J.X. Liang, Y.M. Zhao, X.E. Wang & N.Z. Jin. (2017) Comparison of the molecular interactions of 7′-carboxyalkyl apigenin derivatives with S. cerevisiae α-glucosidase. Computational Biology and Chemistry 67, pages 182-193.
Crossref
Shada J Alabed, Mohammad Khanfar & Mutasem O Taha. (2016) Computer-aided discovery of new FGFR-1 inhibitors followed by in vitro validation . Future Medicinal Chemistry 8:15, pages 1841-1869.
Crossref
Y.J. Qi, Y.M. Zhao, H.N. Lu, X.E. Wang & N.Z. Jin. (2016) Exploring molecular flexibility and the interactions of Quercetin derivatives in the active site of α-glucosidase using molecular docking and charge density analysis. Computational and Theoretical Chemistry 1094, pages 55-68.
Crossref
Areej Abuhammad & Mutasem Taha. (2016) Innovative computer-aided methods for the discovery of new kinase ligands. Future Medicinal Chemistry 8:5, pages 509-526.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.